RESUMEN
Ullmann-type reactions are becoming a major tool in medicinal chemistry. In this article, we describe the use of these Copper-catalyzed reactions with various precursors, acyl-heteroarylamines or pyrazoles of interest for pharmacomodulation. To the medicinal chemist they offer new, usually untapped disconnection approaches to compounds of interest. They thus open the way to new original analogues of bioactive compounds possibly not patented, from common building-blocks. They also allow C to N bioisosteric replacements, which sometimes are synthetically challenging. We report for the first time the critical effect of acetylamino substituents on the regioselective arylation of unsymmetrical pyrazoles that are useful for medicinal chemists. Finally, we have applied this strategy to the design of novel AT(1) receptor antagonists. Though this family has been extensively investigated in the past 30 years, N-arylation and C to N replacement made possible by Ullmann chemistry, can produce original antagonists.
Asunto(s)
Acetamidas/química , Pirazoles/síntesis química , Pirazoles/farmacología , Animales , Células CHO , Línea Celular , Cricetinae , Cricetulus , Humanos , Espectroscopía de Resonancia Magnética , Pirazoles/química , Receptores de Angiotensina/efectos de los fármacos , Espectrometría de Masa por Ionización de ElectrosprayRESUMEN
In situ click chemistry has been successfully applied to probe the ligand binding domain of EthR, a mycobacterial transcriptional regulator known to control the sensitivity of Mycobacterium tuberculosis to several antibiotics. Specific protein-templated ligands were generated in situ from one azide and six clusters of 10 acetylenic fragments. Comparative X-ray structures of EthR complexed with either clicked ligand BDM14950 or its azide precursor showed ligand-dependent conformational impacts on the protein architecture. This approach revealed two mobile phenylalanine residues that control the access to a previously hidden hydrophobic pocket that can be further exploited for the development of structurally diverse EthR inhibitors. This report shows that protein-directed in situ chemistry allows medicinal chemists to explore the conformational space of a ligand-binding pocket and is thus a valuable tool to guide drug design in the complex path of hit-to-lead processes.
Asunto(s)
Antituberculosos/química , Azidas/química , Química Clic/métodos , Mycobacterium tuberculosis/efectos de los fármacos , Oxadiazoles/química , Proteínas Represoras/antagonistas & inhibidores , Proteínas Represoras/química , Antituberculosos/farmacología , Azidas/farmacología , Cristalografía por Rayos X , Evaluación Preclínica de Medicamentos , Ligandos , Mycobacterium tuberculosis/genética , Oxadiazoles/farmacología , Conformación Proteica , Transcripción Genética/efectos de los fármacosRESUMEN
The synthesis and in vivo activities of a series of substituted pyrazole-4-carboxylic acids as hypoglycemic agents are described. Modelization of some potent compounds, comparatively to the metformine, presents certain analogies permitting to predict the design of some novel antidiabetic drugs.